Innovating Works

CHAIMELEON

Financiado
Accelerating the lab to market transition of AI tools for cancer management
CHAIMELEON aims to set up a structured repository for health imaging data to be openly reused in AI experimentation for cancer management. An EU-wide repository will be built as a distributed infrastructure in full compliance with... CHAIMELEON aims to set up a structured repository for health imaging data to be openly reused in AI experimentation for cancer management. An EU-wide repository will be built as a distributed infrastructure in full compliance with legal and ethics regulations in the involved countries. It will build on partner´s experience (e.g. PRIMAGE repository for paediatric cancer and the Euro-BioImaging node for Valencia population, by HULAFE; the Radiomics Imaging Archive by Maastricht University; the national repository DRIM AI France, the Oncology imaging biobank by Pisa University). Clinical partners and external collaborators will populate the Repository with multimodality (MR, CT, PET/CT) imaging and related clinical data for historic and newly diagnosed lung, prostate, colon and rectal cancer patients. A multimodal analytical data engine will facilitate to interpret, extract and exploit the right information stored at the Repository. An ambitious development and implementation of AI-powered pipelines will enable advancement towards automating data deidentification, curation, annotation, integrity securing and images harmonisation, the latest being of the highest importance for enabling reproducibility of Radiomics when using large multiscanner/multicentre image datasets. The usability and performance of the Repository as a tool fostering AI experimentation will be validated, including a validation subphase by other world-class European AI developers, articulated via the organisation of Open Challenges to the AI Community. A set of selected AI tools will undergo early on-silico validation in observational (non-interventional) clinical studies coordinated by leading experts in Gustave Roussy (lung cancer), San Donato (breast), Sapienza (colon and rectal) and La Fe (prostate) hospitals. Their performance will be assessed, including external independent validation, on hallmark clinical decisions in response to some of the currently most important clinical end points in cancer. ver más
28/02/2025
Fundación para la...
9M€
Duración del proyecto: 56 meses Fecha Inicio: 2020-06-02
Fecha Fin: 2025-02-28

Línea de financiación: concedida

El organismo H2020 notifico la concesión del proyecto el día 2020-06-02
Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:
DT-TDS-05-2020: AI for Health Imaging
Cerrada hace 5 años
Presupuesto El presupuesto total del proyecto asciende a 9M€
Líder del proyecto
Fundación para la investigación del Hospital... No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico TRL 4-5 7M